Abstract |
|
Authors | Francis J Giles, Eric J Feldman, Gail J Roboz, Richard A Larson, Steven W Mamus, Jorge E Cortes, Srdan Verstovsek, Stefan Faderl, Moshe Talpaz, Miloslav Beran, Maher Albitar, Susan M O'Brien, Hagop M Kantarjian |
Journal | Leukemia research
(Leuk Res)
Vol. 27
Issue 12
Pg. 1091-6
(Dec 2003)
ISSN: 0145-2126 [Print] England |
PMID | 12921945
(Publication Type: Clinical Trial, Clinical Trial, Phase II, Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Benzamides
- Dioxolanes
- Piperazines
- Pyrimidines
- troxacitabine
- Imatinib Mesylate
- Cytosine
- Protein-Tyrosine Kinases
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents
(administration & dosage, adverse effects, therapeutic use)
- Benzamides
- Cytosine
(administration & dosage, adverse effects, analogs & derivatives, therapeutic use)
- Dioxolanes
(administration & dosage, adverse effects, therapeutic use)
- Drug Resistance, Neoplasm
- Female
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
(drug therapy)
- Male
- Middle Aged
- Piperazines
(therapeutic use)
- Protein-Tyrosine Kinases
(antagonists & inhibitors)
- Pyrimidines
(therapeutic use)
- Remission Induction
- Salvage Therapy
|